参考文献/References:
［1］KOREN G. Fetal risks of maternal pharmacotherapy:identifying signals ［J］. Handbook of Experimental Pharmacology, 2011，205 (205): 285-294.
［2］KOREN G, CAREY N, GAGNON R, et al. Cancer chemotherapy and pregnancy ［J］. Journal of Obstetrics and Gynaecology Canada, 2013 (35): 263-280.
［3］WILLIAMS S F, SCHILSKY R L. Antineoplastic drugs administered during pregnancy ［J］. Seminars Oncology, 2000，27 (6): 618-622.
［4］VAN C K, VERBESSELT R, VAN BREE R, et al. Substantial variation in transplacental transfer of chemotherapeutic agents in a mouse model ［J］. Reproductive Sciences, 2011, 18 (1): 57-63.
［5］Cardonick E, Bhat A, Gilmandyar D, et al. Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature ［J］. Annals of Oncology, 2012, 23 (12):3016-3023.
［6］Amant F, Halaska M J, Fumagalli M, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting ［J］. International Journal of Gynecological Cancer, 2014, 24 (3):394-403.
［7］MIR O, BERVEILLER P, ROPERT S, et al. Use of Platinum derivatives during pregnancy ［J］. Cancer, 2008, 113 (11): 3069-3074.
［8］Demir R, Seval Y, Huppertz B. Vasculogenesis and angiogenesis in the early human placenta ［J］. Acta Histochemica, 2007, 109 (4):257-265.
［9］MIQUEROL L, LANGILLE B L, NAGY A. Embryonic development is disrupted by modest increases in vascular endothelial growth factor gene expression ［J］. Development, 2000, 127 (18): 3941-3946.
［10］Petrou P, Georgalas I, Giavaras G, et al. Early loss of pregnancy after intravitreal bevacizumab injection ［J］. Acta Ophthalmologica, 2010, 88 (4):e136-e136.
［11］CARDONICK E,IRFAN F,TORRES N.The use of neupogen(filgrastim)or neulasta(pegfilgrastim)during pregnancy when chemotherapy is indicated for maternal cancer treatment ［J］. Journal of Cancer Therapy, 2012 (3): 157-161.
［12］AMANT F, VON MINCKWITZ G, HAN S-n, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy:results from an international collaborative study［J］. Journal of Clinical Oncology, 2013 (31): 2532-2539.
［13］CARDONICK E, USMANI A, GHAFFAR S. Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy results of an international registry ［J］. American Journal of Clinical Oncology-Cancer Clinical Trials, 2010, 33 (3): 221-228.
［14］CARDONICK E H, GRINGLAS M B, HUNTER K, et al. Development of children born to mothers with cancer during pregnancy: comparing in utero chemotherapy-exposed children with nonexposed controls ［J］. American Journal of Obstetrics and Gynecology, 2015, 212 (5): 658.e1-658.e8.
［15］PEREG D, KOREN G, LISHNER M. Cancer in pregnancy: Gaps, challenges and solutions ［J］. Cancer Treatment Reviews, 2008, 34 (4): 302-312.
［16］SIEW-FEI N, HEXTAN Y S Ngan. Chemotherapy in pregnancy ［J］. Best Practice&Research Clinical Obstetrics and Gynaecology, 2016，33（10）: 86-101.
［17］HAN S-n, KESIC V I, VAN C K, et al. Cancer in pregnancy:a survey of current clinical practice ［J］. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 2013, 167 (1): 18-23.
［18］FRUSCIO R, VILLA A, CHIARI S, et al. Delivery delay with neoadjuvant chemotherapy for cervical cancer patients during pregnancy: A series of nine cases and literature review ［J］. Gynecologic Oncology, 2012, 126 (2): 192-197.
［19］LI Jing, WANG Li-juan, ZHANG Bing-zhong, et al. Neoadjuvant chemotherapy with paclitaxel plus Platinum for invasive cervical cancer in pregnancy: two case report and literature review ［J］. Archives of Gynecology and Obstetrics, 2011, 284 (3): 779-783.
［20］MODARES G M, KARIMI Z M, BEHTASH N, et al. Preservation of pregnancy in a patient with advanced ovarian cancer at 20 weeks of gestation:case report and literature review ［J］. International Journal of Gynecological Cancer, 2007, 17 (5): 1140-1143.
［21］ZARCHI M K, BEHTASH N, GILANI M M. Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review ［J］. Archives of Gynecology and Obstetrics, 2008, 277 (1): 75-78.
［22］BLAKE E A, CARTER C M, KASHANI B N, et al. Feto-maternal outcomes of pregnancy complicated by ovarian sex-cord stromal tumor:a systematic review of literature ［J］. European Journal of Obstetrics Gynecology and Reproductive Biology, 2014 (175): 1-7.
相似文献/References:
[1]吴池华,刘锦平.妊娠哺乳期乳腺癌的临床问题[J].中国计划生育和妇产科,2009,(05):0.
WU Chi-hua,LIU Jin-ping The department of breast surgery,The academy of science · Sichuan provincal peoples hospital.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(2):0.
[2]夏晓梦,方小玲.妊娠期宫颈细胞学与阴道镜检查的特征与处理[J].中国计划生育和妇产科,2013,(01):0.
XIA Xiao-meng,FANG Xiao-ling*.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[3]李光辉,孔丽君,张为远,等.子痫前期的脂代谢[J].中国计划生育和妇产科,2014,(01):0.
LI Guang-hui,KONG Li-jun,ZHANG Wei-yuan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2014,(2):0.
[4]陈彧,冯欣,杨华,等.妊娠期疾病常用中成药使用原则及禁忌[J].中国计划生育和妇产科,2015,(02):0.
[5]周慧梅,李威,朱兰,等.妊娠期急性阑尾炎诊治进展[J].中国计划生育和妇产科,2015,(02):0.
[6]崔淑娟,马艳芬.妊娠期心理压力与自然流产的关系[J].中国计划生育和妇产科,2015,(03):0.
CUI Shu-juan,MA Yan-fen,[J].Chinese Journal of Family Planning & Gynecotokology,2015,(2):0.
[7]何书励,马良坤,刘俊涛,等.早产和营养[J].中国计划生育和妇产科,2015,(05):0.
[8]杨孜,张为远.如何理解和践行中国妊娠期高血压疾病诊治指南(2015)[J].中国计划生育和妇产科,2016,(04):0.
[9]李力,顾焱,陈建坤,等.妊娠期高血压疾病与产后出血[J].中国计划生育和妇产科,2016,(04):0.
[10]付婷,侯顺玉.妊娠期暴发性1型糖尿病发生死胎1例及相关文献复习[J].中国计划生育和妇产科,2016,(06):0.